Zoryl-M2 Tablet PR is a prescription medication for treating type 2 diabetes in adults. It contains Metformin and Glimepiride.
Metformin belongs to a class of medications called biguanides and helps to lower blood sugar levels by reducing glucose production in the liver and improving insulin sensitivity. Glimepiride belongs to a class of medications called sulfonylureas and works by stimulating the pancreas to release more insulin.
Zoryl-M2 Tablet PR is an extended-release formulation. The medication is released slowly over time, providing a steady and consistent dose of Metformin and Glimepiride throughout the day. This helps to maintain blood sugar levels within a normal range and reduce the risk of complications associated with uncontrolled diabetes, such as kidney damage, nerve damage, and vision loss.
The medication is typically prescribed to individuals with type 2 diabetes who cannot manage their blood sugar levels with diet. A healthcare provider may adjust the dosage based on the patient's blood sugar levels and response to treatment.
Zoryl-M2 Tablet PR is not recommended for individuals with type 1 diabetes, as their bodies do not produce insulin, which is necessary for the medication to work effectively. It is also not recommended for individuals with diabetic ketoacidosis, which occurs when the body produces high levels of blood acids called ketones.
Like all medications, Zoryl-M2 Tablet PR may cause side effects in some individuals. However, if the side effects persist or become severe, it is essential to contact a healthcare provider immediately.